Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Dividend vs. Buy Back

It was just one big deal with Philips which propably brings in a "big" amount of money. Deawoo and the other deals are IMO in a lower range.

We still need money due to the TX case and the reex. Furthermore, we need much more money to realize a take over etc. of another company. My own road map would be to save as much money as possible for a share buy back and the second revenue stream. If we really get a big ammount due to a settlement in TX and deals which follow closely to a settlement, I agree to give out a little dividend to atract more investors. Like mentioned, a share buy back lowers the free float. If we will see the expected good news, this could help the share price increas much more!

GTLA

S402005

 

  

 

 

Share
New Message
Please login to post a reply